A new study found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain region associated with psychosis.

Study suggests accelerated brain ageing is a factor in the development of schizophrenia – and can be measured using a simple blood test.

This review examined whether switching to a different antipsychotic medicine, as opposed to continuing treatment with the same one, improved people's response rates, alleviated overall and specific ...

Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection by a health care professional.

Secondary psychosis caused by a lesion was mapped to the hippocampus, with a peak in the posterior subiculum and was consistent across symptoms.

A McGill University-led study found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain ...

Luye Pharma launches Erzofri ER injectable suspension to treat schizophrenia and schizoaffective disorder in US market: Princeton, New Jersey Tuesday, April 8, 2025, 15:00 Hrs [IS ...

Luye Pharma Group today announced that ERZOFRI® extended-release injectable suspension is now available for commercial sale ...

Dr Mary Davoren gave evidence for a second day on Thursday in the trial of Brian Ibe (23), who is charged with the murder of ...

When a murder accused threatened and demanded money from an elderly man, whom he would later fatally assault, he was not ...

“Both can involve psychotic episodes, but in BPD, these are usually short and triggered by stress, while in schizophrenia, they tend to last longer,” says Joel Frank, PsyD, a clinical ...